Chempaq receives further round of venture capital  

The Danish medico company gets funding to ensure launch of its groundbreaking mini-analyzer in 2004

Danish medico company Chempaq has received its second round of venture capital funding which will ensure a market introduction of the company’s compact mini-analyzer for blood cell measurement in spring 2004. According to venture company Symbion Capital which has invested in Chempaq together with InnFond p/s and the Danish Growth Fund, Chempaq has reached all previous milestones. The technology has considerable potential which can simplify the diagnosis of a number of diseases.


Chempaq’s analyzer technology is built around a sensor which enables easy-to-perform diagnostics on a blood drop from the fingertip. The analyzer is so compact that it can be transported in a briefcase, while conventional measuring instruments in hospitals are very large and priced accordingly at around DKK 1 million. The investors and Chempaq envision that the new technology will move blood analyses from hospital laboratories to outpatient clinics and GP surgeries.


Chempaq is a spin-off from the Microelectronics Center at the Technical University of Denmark and is based in Symbion Science Park in Copenhagen. The news is reported by

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×